Evidence map›Paper›PMID 30397033›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2018

Filtering Next-Generation Sequencing of the Ig Gene Repertoire Data Using Antibody Structural Information.

Aleksandr Kovaltsuk, Konrad Krawczyk, Sebastian Kelm, James Snowden, Charlotte M Deane

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Aleksandr KovaltsukDepartment of Statistics, University of Oxford, Oxford OX1 3LB, United Kingdom; and.ORCID 0000-0003-3806-8302
Konrad KrawczykDepartment of Statistics, University of Oxford, Oxford OX1 3LB, United Kingdom; and.
Sebastian KelmUCB Pharma, Slough SL1 3WE, United Kingdom.ORCID 0000-0001-7146-9322
James SnowdenUCB Pharma, Slough SL1 3WE, United Kingdom.ORCID 0000-0003-4855-7329
Charlotte M DeaneDepartment of Statistics, University of Oxford, Oxford OX1 3LB, United Kingdom; and deane@stats.ox.ac.uk.ORCID 0000-0003-1388-2252

Funding

Biotechnology and Biological Sciences Research Council BB/M011224/1
6 · The paper itself

Abstract

Next-generation sequencing of the Ig gene repertoire (Ig-seq) produces large volumes of information at the nucleotide sequence level. Such data have improved our understanding of immune systems across numerous species and have already been successfully applied in vaccine development and drug discovery. However, the high-throughput nature of Ig-seq means that it is afflicted by high error rates. This has led to the development of error-correction approaches. Computational error-correction methods use sequence information alone, primarily designating sequences as likely to be correct if they are observed frequently. In this work, we describe an orthogonal method for filtering Ig-seq data, which considers the structural viability of each sequence. A typical natural Ab structure requires the presence of a disulfide bridge within each of its variable chains to maintain the fold. Our Ab Sequence Selector (ABOSS) uses the presence/absence of this bridge as a way of both identifying structurally viable sequences and estimating the sequencing error rate. On simulated Ig-seq datasets, ABOSS is able to identify more than 99% of structurally viable sequences. Applying our method to six independent Ig-seq datasets (one mouse and five human), we show that our error calculations are in line with previous experimental and computational error estimates. We also show how ABOSS is able to identify structurally impossible sequences missed by other error-correction methods.

Indexed as

SoftwareAlgorithmsAnimalsComputational BiologyDatabases as TopicDrug DevelopmentHigh-Throughput Nucleotide SequencingHumansImmunoglobulinsMiceProtein ConformationQuality ControlScientific Experimental ErrorStructure-Activity RelationshipVaccinesImmunoglobulinsVaccines

Identifiers

PMID30397033
PMCPMC6485405

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.